Ask AI
Bill117th CongressFiled May 26, 2022Health
S. 4338

Increasing Transparency in Generic Drug Applications Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (May 26, 2022)

Increasing Transparency in Generic Drug Applications Act

This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

What just happenedMay 26, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Sen. Hassan, Margaret Wood [D-NH](D-NH)Sponsor
1 cosponsor1 R
Read on Congress.gov
1cosponsors1committees2actions2related bills4subjects
  1. May 26, 2022IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. May 26, 2022IntroReferral10000

    Introduced in Senate

Increasing Transparency in Generic Drug Applications Act — Informed